baseline, mean+SD; P=.0001), whereas thallium activity was unchanged from baseline. This reduction in cardiac MIBG activity with heart failure was associated with increased intraimage variability in the distribution of MIBG activity (21±8% versus 13±7% at baseline, mean±SD; P=.0001). The MIBG heart-to-lung ratio was calculated for all groups to control for the inhibitory effect that plasma norepinephrine has on the neuronal uptake of MIBG. There was a positive correlation between LV tissue norepinephrine and the MIBG heart-to-lung ratio (r=.67; P<.001; n=22), for which the group 2 heart failure animals had the lowest values. No relation existed between plasma norepinephrine concentration and the MIBG heart-to-lung ratio. In addition, regional LV tissue norepinephrine concentration and MIBG activity were both lowest at the apex in normal (group 1) and heart failure (group 2) dogs. The MIBG heart-to-lung ratio also correlated inversely with cardiac filling pressure (r= -.59; P<.05) and heart rate (r= -.65; P<.01) and positively with cardiac output (r=.53; P<.05).
Concusions Heart failure is associated with severe cardiac adrenergic dysfunction manifested by reduced MIBG activity and increased heterogeneity in the LV distribution of MIBG. Furthermore, MIBG scintigraphy is a simple noninvasive method for assessing global and regional LV tissue norepinephrine levels. (Circulation. 1994; 89:2843 -2851 Key Words * heart failure, congestive * nervous system * metaiodobenzylguanidine * norepinephrine T here is general agreement that activation of the sympathetic nervous system is important in the pathophysiology of congestive heart failure,"2 and recent studies demonstrate that this activation precedes the clinical manifestations of heart failure. prolonged sympathetic activation may ultimately contribute to the progression of heart failure and arrhythmias. [8] [9] [10] In an attempt to understand the mechanism by which sympathetic neural overactivity may adversely affect the present study, this technique was applied to an experimental canine model of heart failure produced by rapid ventricular pacing. This model is characterized by the predictable development of biventricular dilatation without hypertrophy and hemodynamic changes similar to human heart failure.25-27 As in human heart failure, plasma norepinephrine levels are elevated, and left ventricular tissue norepinephrine and baroreceptor sensitivity are reduced. 4, 25, 28, 29 To assess a spectrum of severity of pacing-induced heart failure, we examined three groups of animals, a group of normal dogs and two groups that were paced to heart failure of various hemodynamic severities.
Accordingly, the hypotheses tested in this study were that (1) pacing-induced heart failure produces cardiac sympathetic neuronal dysfunction as manifested by reduced myocardial MIBG activity and (2) Echocardiographic and hemodynamic studies were repeated at 3 weeks in group 2 and at 7 weeks in group 3. These measurements were obtained in sinus rhythm according to the above protocol after a 15-minute stabilization period subsequent to deactivation of pacing. Paired echocardiographic data were available for all paced dogs, and hemodynamic studies were completed for 11 dogs.
Imaging Protocol
The dogs were injected while in sinus rhythm with 5 mCi IV 1231-MIBG and 4 hours later received 2 mCi 20`TI to simultaneously assess myocardial perfusion.20 Thirty minutes later, dual-isotope imaging was commenced with the dogs in sinus rhythm. The 5-hour delay in imaging was selected to maximize the amount of MIBG in the neuronal versus the extraneuronal compartment.24 Dual-isotope imaging was performed at baseline in the group 1 dogs; at both the baseline and 3-week time points for group 2; and in group 3 at 7 weeks.
In preparation for dual-isotope imaging, the dogs were fasted for 12 hours before receiving 2 to 4 mg IV of morphine sulfate, titrated to produce mild sedation, and then were suspended in a sling. An Elscint tomographic system with a general all-purpose collimator was used with 20% windows around the 72-keV and 159-keV photopeaks of 20`T1 and 'I, respectively. Five-minute planar acquisition was performed in the anterior projection in a 256x256 matrix. A tomographic study was then performed over a 15-minute period with 180°c ontinuous circular acquisition in 30 increments starting from the 450 right anterior oblique position. Sixty images were acquired and stored in a 64x64 matrix. Tomographic reconstruction was performed with a Butterworth filter with a cutoff of 0.35 in the fifth order. Horizontal short-axis, vertical, and horizontal long-axis slices, each 1 pixel thick, were generated (Fig 1) .
Image Processing and Analysis
For all data processing, 1231-MIBG and 20MT1 counts per minute were corrected for decay, and both were normalized to a 1-MBq (0.027-mCi) dose.
Planar Images 13I-MIBG activity in the heart and lung were measured in regions of interest (ROIs), 89 pixels in size, obtained from the anterior view. The means of two ROIs were used to calculate a ratio of heart-to-lung '"I-MIBG activity (Fig 2) . Pulmonary MIBG activity was used in this way as an internal control for the negative competitive effect that an elevated plasma norepinephrine level may have on the uptake of MIBG (uptake-1). [21] [22] [23] We assessed the interobserver variability of the MIBG heart-to-lung ratio in 22 dogs and found an excellent correlation (r=.85, P=.0001) with a low SEE (0.106). Similarly, ROIs were created over the liver and mediastinum, and '"I-MIBG activity in these areas was compared with cardiac activity. Since the lung and liver are sympathetically innervated, the MIBG activity in these organs was also examined to exclude a generalized effect of heart failure on sympathetic function as opposed to a specific effect on cardiac adrenergic function.
Tomographic Images
An ROI was drawn around the left ventricular MIBG and 201T1 images, and both radionuclides were quantified (counts per megabecquerel per pixel) separately. Quantification of regional left ventricular MIBG and 20ITI counts was performed for the lateral, inferior, and anterior walls and septum from the midventricular horizontal short-axis slice, and global left ventricular activity was calculated from a mean of these four regions. Apical counts were quantified from a mean of the midventricular vertical and horizontal long-axis slices. The ratio of MIBG to 201fl was determined for the separate left control (left) demonstrate reduced activity at the apex of the left ventricle, whereas the corresponding thallium images are normal. In contrast, the study performed after 3 weeks of pacing-induced heart failure (right) shows marked reductions in MIBG activity compared with the control study and with the corresponding thallium images. The distribution of MIBG at heart failure is more heterogeneous, with the decrease in MIBG activity, in this example, being greater in the septum and inferior wall. An apical defect is present on both the MIBG and thallium images at heart failure but is more extensive on the former. ventricular regions and for the mean of the midventricular horizontal short-axis slice (Fig 3) to account for the potential effect that perfusion could have on MIBG uptake. We assessed the interobserver variability of the MIBG-to-2'TI. ratio in 20 dogs and found an excellent correlation (r=.94, P=.0001) with a low SEE (0.081). Intraimage regional variability in MIBG activity was calculated from the midventricular horizontal short-axis slice as the difference in the maximum and minimum regional counts divided by the maximum regional counts and expressed as a percentage.3' FIG 2. Anterior planar image of cardiac and pulmonary [12J1meta-iodobenzylguanidine (MIBG) activity. The mean of two left ventricular and two pulmonary regions of interest were used to calculate a ratio of heart-to-lung MIBG activity, which in this example, at control, is 1.8.
After completion of the final scintigraphic study, dogs were killed with a lethal dose of KCI. Myocardial tissue from the lateral free wall of the left ventricle was removed and stored at -80°C. In addition, for the purposes of regional left ventricular analysis, myocardium from the septum, anterior wall, and apex was obtained from four dogs in group 1 and seven dogs in group 2.
Plasma and left ventricular tissue norepinephrine contents were determined by high-performance liquid chromatography with electrochemical detection. 
Statistical Analysis
Intragroup comparisons were performed by paired t tests.
Comparisons between groups of dogs were made with ANOVA and Tukey's test. To study the regional variations in left ventricular MIBG activity and norepinephrine content, two-way ANOVA with repeated measures and Tukey's test were used. Associations between tissue and plasma norepinephrine versus MIBG heart-to-lung ratio; and heart rate, pulmonary capillary wedge pressure, and cardiac output versus tissue norepinephrine were studied with regression analysis. Data are expressed as mean--SD, and a probability of P<.05 was considered to be significant.
Results

Continuous Pacing Regimen (Group 2)
Since the principal study objective was to examine the effect of pacing-induced heart failure on cardiac sympathetic function as assessed by MIBG Left ventricular MIBG activity for group is displayed in Table 1 . There was a reduction in global cardiac MIBG activity at heart failure (from 0.29±0.05 to 0.17±0.04 counts per megabecquerel per pixel at baseline and heart failure, respectively: P=.0001), with MIBG activity decreasing significantly in all regions of the left ventricle. There was also regional variation in left ventricular MIBG activity, with the apex having the least and the anterior wall having the greatest activity both at baseline and after 3 weeks of pacing (Table 1) . There was no change in global (0.50±0.11 versus 0.46±0.08 counts per megabecquerel per pixel at baseline and heart failure, respectively; P=NS) or regional left ventricular perfusion, as assessed by`'Tl, associated with 3 weeks of pacing. Hence, the global M1BG-to- §`Tl ratio was reduced with the development of pacinginduced heart failure (0.58±0.07 to 0.39±0.04, P<.005).
There was greater intraimage variability in the distribution of left ventricular MIBG activity with the development of pacing-induced heart failure (13±7% for baseline versus 21±8% for 3-week pacing, P=.0001; Fig 1) .
In Table 2 . cardiac MIBG activity is compared with that of other organs for the group 2 animals. Left ventricular MIBG activity was reduced from the base- line value with the development of heart failure (18.91±2.84 to 14.28±2.79 counts per megabecquerel, P<.005). Notably, the reduction in MIBG activity was selective for the heart, since pulmonary, mediastinal, and hepatic activity remained unchanged with the development of heart failure. The MIBG heart-to-lung ratio decreased significantly with 3 weeks of pacing (1.92±0.16 to 1.48±0.25, P-.0001), and similar changes (P<.005) were observed in the MIBG heart-to-mediastinum and heart-to-liver ratios.
Intermittent Pacing Regimen (Group 3)
The intermittent pacing regimen in group 3 produced a significant increase in the pulmonary capillary wedge pressure (8±2 to 23±8 mm Hg, P<.005) and decreases in cardiac output (205±77 to 118±23 mL min-'kg-1, P<.05) and left ventricular ejection fraction (50±8% to 23±5%, P<.005) compared with baseline. With the development of heart failure, both group 2 and group 3 had similar decreases in ejection fraction. However, the intermittently paced animals had hemodynamically less severe heart failure, with both a lower pulmonary capillary wedge pressure (23±8 mm Hg for group 3 versus 38±7 mm Hg for group 2, P<.01) and heart rate (126±20 beats per minute for group 3 and 161±9 beats per minute for group 2, Pc.01). There was also a trend (P=.057) for a higher cardiac output at heart failure in There was a positive correlation between left ventricular tissue norepinephrine and the MIBG heart-to-lung ratio for all animals (r=.67, P<.001, n=22) (Fig 6) . Normal dogs (group 1) had the highest MIBG and tissue norepinephrine levels, group 2 animals with the most severe heart failure had the lowest values, and group 3 dogs had intermediate values. Both the pulmonary capillary wedge pressure (r= -.59, P<.05, n= 16) and heart rate (r= -.65, P<.01, n= 16) for the groups 2 and 3 animals were negatively correlated with the MIBG heart-to-lung ratio. For these two groups, there was also a positive correlation between cardiac output and the MIBG heart-to-lung ratio (r=.53, P<.05, n= 16) . No correlation was found between plasma norepinephrine and the MIBG heart-to-lung ratio. Modest correlations also existed between left ventricular tissue norepinephrine and the MIBG heart-to-mediastinum ratio (r=.56, P<.01, n=22) and the heart-to-liver ratio (r=.43, P<.05, n=22) for all animals.
Regional left ventricular MIBG activity on the tomographic study and tissue norepinephrine levels for the data for the three groups of animals (-indicates group 1, n=8; A, group 2 at heart failure, n=9; and *, group 3, n=6). Cardiac MIBG activity is lower in group 2 at heart failure compared with the other groups, whereas pulmonary, mediastinal, and hepatic activity is similar among the three groups (A). The MIBG heart-to-lung, heart-to-mediastinum, and heart-to-liver ratios are also reduced for group 2 at heart failure (B 
Discussion
The principal novel findings of the present study are that (1) pacing-induced heart failure is associated with a reduction in left ventricular MIBG activity, which is independent of any change in myocardial perfusion as assessed by thallium imaging; (2) there is greater heterogeneity in the distribution of MIBG in the left ventricle with the development of heart failure; (3) the MIBG heart-to-lung ratio is positively correlated with left ventricular tissue norepinephrine content, and MIBG scintigraphy detected the regional variation in tissue norepinephrine levels; and (4) the MIBG heartto-lung ratio is positively correlated with cardiac output and inversely correlated with pulmonary capillary wedge pressure and heart rate.
Previous investigations have shown enhanced early washout of MIBG3032 with reduced myocardial MIBG activity on delayed images in patients with dilated cardiomyopathy.30,32-34 Similar results were reported in a canine model of left ventricular hypertrophy and failure. 35 Hemodynamics were not reported in these studies30323335; thus, an assessment of the interaction between the hemodynamic severity of heart failure and MIBG activity cannot be made. Moreover, it is important to note that a concomitant assessment of myocardial perfusion to ensure the adequate delivery of MIBG to the myocardium was not made in these studies; this is a particularly important caveat in the canine study, 35 given the presence of left ventricular hypertrophy. 36 Our data demonstrate that pacing-induced heart failure is associated with a reduction in left ventricular myocardial MIBG activity, whereas perfusion, as assessed by thallium, remains unchanged. This latter finding is consistent with previous studies in this model that have demonstrated increased left ventricular myocardial blood flow without any change in its overall transmural distribution and the absence of myocardial lactate production.37,38 These data corroborate the use of MIBG in this model as a surrogate for cardiac sympathetic neuronal function without the requirement for a simultaneous assessment of myocardial perfusion.
As mentioned, studies in patients with dilated cardiomyopathy30,32 and in a canine model of heart failure35 have reported an enhanced early washout of myocardial MIBG. However, a general limitation of MIBG imaging is that it is less than ideal for performing kinetic analyses of cardiac sympathetic function because of its significant early nonneuronal uptake, which is minimized with delayed imaging 3 to 5 hours after injection.20,24 Recent studies suggest, however, that the non- neuronal uptake of MIBG in the human heart may be considerably less than in the dog32'39; thus, MIBG kinetics may better approximate norepinephrine kinetics in the human heart. Interpretation of the previous studies in dilated cardiomyopathy30'32'33 is also limited by the concurrent use of digoxin and angiotensinconverting enzyme inhibitors, which can alter sympathetic activity40-42 and possibly myocardial MIBG activity.22'43 Norepinephrine competes with MIBG for neuronal uptake (uptake-1) and can inhibit MIBG accumulation.21-23 Therefore, we compared myocardial with pulmonary MIBG activity to control for any negative competitive effect that an elevated plasma norepinephrine level might have on MIBG uptake, since both of these organs would be exposed to circulating norepinephrine. Previous studies examining the potential for an elevation in pulmonary arterial pressure to affect norepinephrine extraction by the lungs have revealed conflicting results. 44, 45 In the present study, there was not a significant change in pulmonary MIBG activity.
Our rationale for selecting the lungs as an internal control for this potential effect of circulating norepinephrine was that (1) although they are anatomically extraneuronal, pulmonary endothelial cells actively take up MIBG and norepinephrine by the uptake-1 process2146; (2) pulmonary MIBG accumulation can be competitively reduced by norepinephrine and by the uptake-1 inhibitor imipramine'7'21; and (3) pulmonary sympathetic activity, as assessed by norepinephrine spillover, remains unchanged in heart failure. 12 We found a positive correlation between left ventricular tissue norepinephrine concentration and the MIBG heart-to-lung ratio across a spectrum of physiological circumstances. One other study33 reported a positive correlation between myocardial norepinephrine content and the ratio of myocardial-to-mediastinal MIBG activity; this association was found in the present study but was less significant than the correlation between tissue norepinephrine and the MIBG heart-to-lung ratio. The mediastinum is a heterogeneous structure that has not been demonstrated to possess uptake-1. Thus, it may be inferior to the lungs when used for comparison with cardiac MIBG activity in the setting of elevated circulating norepinephrine levels for the reasons previously outlined.
Assessment of the normal pattern of sympathetic innervation in dogs has 'previously demonstrated reduced levels of norepinephrine at the apex compared with the base.47-49 The findings of the present study demonstrate that myocardial MIBG activity can map the normal regional variation in canine myocardial norepinephrine levels by showing a matched reduction in apical MIBG activity and norepinephrine content. This pattern of reduced apical MIBG activity and norepinephrine content was also present at heart failure. Therefore, the regional distribution of MIBG in the heart appears to correspond to that of the adrenergic nervous system.
Pacing-induced heart failure was associated with increased heterogeneity in the left ventricular distribution of MIBG; this may correspond to alterations in cardiac innervation during heart failure. This finding has previously been reported in patients with dilated cardiomyopathy. 30 The mechanism underlying this pattern of MIBG distribution with pacing-induced heart failure is unknown, but destruction of adrenergic nerve terminals or increased myocardial fibrosis is unlikely, given the paucity of histological findings in this model and also the potential for functional recovery, which is accompanied and may in part be mediated by the restoration of tissue norepinephrine levels.50'51 However, the ability to noninvasively detect global and regional differences in cardiac adrenergic activity may eventually prove to be of prognostic value in heart failure, since heterogeneous catecholamine stimulation by itself can cause nonuniformity of both systolic and diastolic function and lead to a deterioration of overall ventricular function.52 '53 Moreover, heterogeneity of sympathetic innervation may increase the dispersion of electrical refractoriness and thereby promote reentry arrhythmias.54 Therefore, cardiac MIBG scintigraphy may be useful as a prognostic indicator in heart failure, as recently suggested by Merlet et al. 55 The mechanism for the reduction in left ventricular tissue norepinephrine and MIBG activity in pacinginduced heart failure was not evaluated in the present study. Studies in a variety of other heart failure models have revealed often conflicting results and attributed the decrease in cardiac norepinephrine content to decreased neuronal uptake56'57 and release56 of norepinephrine, increased turnover or release of norepinephrine58-60 with preserved neuronal reuptake,60 and decreased synthesis of norepinephrine.61 Further studies in the pacing model are needed to address this issue.
In the present study, tissue norepinephrine concentrations distinguished the three groups of dogs, whereas plasma levels were of less discriminatory value and did not correlate with the MIBG heart-to-lung ratio. These findings are not surprising, given that plasma norepinephrine is derived from total body adrenergic activity and its subsequent clearance. The latter is dependent on hemodynamic factors and has been reported to be reduced in heart failure.12'62 Thus, plasma norepinephrine is not an accurate index of cardiac adrenergic activity, and perhaps this may account for its relatively low prognostic value in heart failure when it is assessed as a continuum. 63 Furthermore, the hypothesis that dysfunction of the efferent limb of the sympathetic nervous system may be predominantly localized to the failing heart is supported by the selective reduction in myocardial MIBG activity compared with other organs, reported in this study and others.30 '32 In summary, this report demonstrates that pacinginduced heart failure is associated with severe cardiac adrenergic dysfunction manifested by reduced MIBG activity and increased heterogeneity in the left ventricular distribution of MIBG. Furthermore, we have provided evidence that cardiac MIBG scintigraphy is a simple noninvasive method for assessing global and regional myocardial norepinephrine levels.
